LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) OverviewTrack LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s EBIT ($-360M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Mar 31, 2024
Trailing 12 months ending Mar 31, 2024
LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) (YSBPW) currently reports a EBIT of $-360M as of March 2024. That is below the sector sector average of $-69M. Use the charts on this page to explore LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s EBIT history and peer comparisons.
LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s EBIT of $-360M is lower than the its sector sector average of $-69M. That is roughly 418.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) reported $-360M in EBIT as of March 2024. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current EBIT of $-360M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-69M. From there, open related valuation or income-statement pages for LakeShore Biopharma Co Ltd. - Warrants (15/03/2028), and consider following YSBPW for alerts when major investors trade the stock.
